A Day Up For Provention Bio, Inc.
Fri, Jan 28, 2022 at 05:30 PM
Provention Bio, Inc. (PRVB:NASDAQ) rocketted at $4.16, representing a gain of 22.4%. On Thu, Jan 27, 2022, PRVB:NASDAQ touched a New 2-Week Low of $3.4. The stock appeared on our News Catalysts scanner on Fri, Jan 28, 2022 at 02:43 PM in the 'MISCELLANEOUS' category. From Fri, Jan 14, 2022, the stock recorded 12.50% Up Days and 44.44% Green Days
The stock spiked on Mon, Nov 22, 2021 at $7.72 with a volume of 6M+.
About Provention Bio, Inc. (PRVB:NASDAQ)
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
Top 10 Gainers:
- Knightscope Inc. (KSCP:NASDAQ), 175.63%
- Option Care Health, Inc. (BIOS:NASDAQ), 100%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 87.93%
- Yoshitsu Co. Ltd (TKLF:NASDAQ), 33.33%
- Advaxis, Inc. (ADXS:NASDAQ), 25.11%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 23.67%
- Vaccinex, Inc. (VCNX:NASDAQ), 23.5%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 23.35%
- Provention Bio, Inc. (PRVB:NASDAQ), 22.35%
- Rallybio Corporation (RLYB:NASDAQ), 21.54%